Nigeria Strikes Deal with Serum Institute of India

Nigeria will start building a vaccine plant by end of the year after signing a contract manufacturing agreement with the Serum Institute of India for local production of the jabs, the country’s health minister said. The country struck the deal with the world’s biggest vaccine manufacturer on Wednesday, Health Minister Osagie Ehanire said at a briefing in the capital, Abuja. The plant should be producing routine vaccines -- initially against polio, measles and yellow fever, among others -- by 2028, he added.